Caci International Inc
$18.54B- Market cap
- $13.78B
- Debt
- +$4.95B
- Cash
- −$191.76M
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: CACI stock price at discount vs LH $623.61 current versus $755.03 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LH's multiple
Implied fair value · at CACI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CACI FY 2026 (ended Jun 30, 2026) · LH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Capital structure 83% equity / 17% debt · EV / Revenue 2.26x · EV / EBITDA 17.36x
LH carries the larger enterprise value at $31.56B against $18.54B; CACI trades on the lower EV / Revenue multiple (1.94x vs 2.26x); CACI on the lower EV / EBITDA (17.07x vs 17.36x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CACI INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
LABCORP HOLDINGS INC. · implied price per share
Bear
$113.84
Base
$138.62
Bull
$182.73
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.11x
0.65x
Net debt / EBITDA
Leverage against operating earnings
4.38x
2.78x
Cash and equivalents
Liquid reserves on the balance sheet
$191.76M
$532.30M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Science Applications International Corp
CACI vs SAIC
KBR, INC.
CACI vs KBR
Booz Allen Hamilton Holding Corp
CACI vs BAH
Leidos Holdings, Inc.
CACI vs LDOS
JACOBS SOLUTIONS INC.
CACI vs J
THERMO FISHER SCIENTIFIC INC.
CACI vs TMO
DANAHER CORP /DE/
CACI vs DHR
QUEST DIAGNOSTICS INC
CACI vs DGX
WEST PHARMACEUTICAL SERVICES INC
CACI vs WST
BAXTER INTERNATIONAL INC
CACI vs BAX
MCKESSON CORP
CACI vs MCK
$4.95B
$5.58B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.